Abstract
The serine proteases of the mammalian kidney and urine, known as kallikreins, are generally considered to be glandular kallikreins, distinct from the plasma enzyme and its precursor. (The isolation, purification and behavior of renal and urinary kallikrein have been discussed in detail elsewhere in this volume by Fiedler.) Despite the long continued interest in the properties of these purified glandular kallikreins, there is little information available about the cellular localization, regulation, or role of the enzymes of the entire kallikrein-kinin system within mammalian kidney and urine. However, interest in the kallikrein-kinin system and its relation to kidney function has increased markedly since publication of the previous edition of the Handbook volume on this subject (Erdös, 1970). This interest has been stimulated by studies on the localization of the enzyme and by relating both kallikrein and kinins to specific renal functions, to certain hormones which affect the kidney, or to some common pathologic states.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Abe, K, Seino, M, Otsuka, Y, Yoshinaga, K.: Urinary kallikrein excretion and sodium metabolism in human hypertension. In: Chemistry and biology of the kallikrein-kinin system in health and disease. Pisano, J. J, Austen, K.F. (eds.), pp. 411–414. Fogarty Internat. Center Proc. No. 27. Washington: U.S. Gov. Printing Office 1977
Adetuyibi, A, Mills, I.H.: Relation between urinary kallikrein and renal function, hypertension, and excretion of sodium and water in man. Lancet 1972/11,203–207
Albertini, R, Roblero, J, Corthorn, J, Croxatto, H.R.: Blood kininogen in uninephrectomized and hypertensive rats. Acta. Physiol. Lat. Am. 24,443–447 (1974)
Amundsen, E, Nustad, K, Waaler, B.: A stable substrate for the assay of plasma kinin-forming enzymes. Br. J. Pharmacol. 21, 500–508 (1963)
Amundsen, E, Svendsen, L, Vennerød, A.M., Laake, K.: Determination of plasma kallikrein with a new chromogenic tripeptide derivative. In: Chemistry and biology of the kallikreinkinin system in health and disease. Pisano, J.J, Austen, K.F. (eds.), pp. 215–220. Fogarty Internat. Center Proc. No. 27. Washington: U.S. Gov. Printing Office 1977
Antonello, A, Baggio, B, Favaro, S, Zen, A, Sandei, F, Todesco, S, Borsatti, A.: Effect of uninephrectomy on tissue kallikrein concentration of the remaining kidney. Biomedicine 23, 303–306 (1975)
Arrigoni-Martelli, E, Nielsen, C. K.: Urinary kallikrein excretion in normotensive and spontaneously hypertensive rats. Acta Pharmacol. Toxicol. (Kbh.) 37,177–184 (1975)
Bagdasarian, A, Talamo, R.C, Colman, R.W.: Isolation of high molecular weight activators of human plasma prekallikrein. J. Biol. Chem. 248,3456–3463 (1973)
Bagdasarian, A, Lahiri, B, Talamo, R.C, Wong, P, Colman, R.W.: Immunochemical studies of plasma kallikrein. J. Clin. Invest. 54,1444–1454 (1974)
Baggio, B, Favoro, S, Antonello, A, Zen, A, Zen, F, Borsatti, A.: Subcellular localization of renin and kallikrein in rat kidney. Ital. J. Biochem. 24,199–206 (1975)
Barraclough, M.A, Mills, I. H.: Effect of bradykinin on renal function. Clin. Sci. 28, 69–14 (1965)
Barton, S, Sanders, E.J, Schachter, M, Uddin, M.: Autonomic nerve stimulation, kallikrein content and acinar cell granules of the cat’s submandibular gland. J. Physiol. (Lond.) 251, 363–369 (1975)
Beaven, V, Pierce, J, Pisano, J.: A sensitive isotopic procedure for the assay of esterase activity: Measurement of human urinary kallikrein. Clin. Chim. Acta 32,67–73 (1971)
Beraldo, W.T, Feldberg, W, Hilton, S.M.: Experiments on the factor in urine forming substance U. J. Physiol. (Lond.) 133,558–565 (1956)
Beraldo, W.T, Lauar, N.S, Siqueira, G, Heneine, I.F, Catanzaro, O.L.: Peculiarities of the oxytocic action of rat urinary kallikrein. In: Chemistry and biology of the kallikrein-kinin system in health and disease. Pisano, J.J, Austen, K.F. (eds.), pp. 375–378. Fogarty Internat. Center Proc. No. 27. Washington: U.S. Gov. Printing Office 1977
Bevan, D.R, Macfarlane, N.A.A, Mills, I.H.: The dependence of urinary kallikrein excretion on renal artery pressure. J. Physiol. (Lond.) 241,34P–35P (1974)
Carretero, O.A, Oza, N.B.: Urinary kallikrein, sodium metabolism and hypertension. In: Proceedings of an international workshop conference of mechanisms of hypertension. Sambhi, M. (ed.), pp. 390–399. Amsterdam: Excerpta Medica Foundation 1973
Carretero, O.A, Scicli, A.G.: Renal kallikrein: its localization and possible role in renal function. Fed. Proc. 35,194–198 (1976)
Carretero, O.A, Oza, N.B, Scicli, A.G, Schork, A.: Renal tissue kallikrein, plasma renin, and plasma aldosterone in renal hypertension. Acta Physiol. Lat. Am. 24,448–452 (1974)
Carretero, O.A, Oza, N.B, Piwonska, A, Ocholik, T, Scicli, A.G.: Measurement of urinary kallikrein activity by kinin radioimmunoassay. Biochem. Pharmacol. 25,1–6 (1976)
Carretero, O.A, Scicli, A.G, Piwonska, A, Koch, J.: Urinary kallikrein in rats bred for susceptibility and resistance to the hypertensive effect of salt and in New Zealand genetically hypertensive rats. Mayo Clin. Proc. 52,465–467 (1977)
Carretero, O.A, Amin, V.M, Ocholik, T, Scicli, A.G, Koch, J.: Urinary kallikrein in rats bred for their susceptibility and resistance to the hypertensive effect of salt. A new radioimmunoassay for its direct determination. Circ. Res. 42,727–731 (1978)
Carvalho, I.F.: Studies on the kinin-forming enzyme (kininogenin) of rat kidney. In: Kidney hormones. Fisher, J.W. (ed.), pp. 585–601. London, New York: Academic Press 1971
Carvalho, I.F, Diniz, C.R.: Kinin forming enzyme (kininogenin) in rat kidney. Ann. N.Y. Acad. Sci. 116,912–917 (1964)
Carvalho, I.F, Diniz, C.R.: Kinin forming enzyme (kininogenin) in homogenates of rat kidney. Biochim. Biophys. Acta 128,136–148 (1966)
Chao, J.: Activity and structural changes of purified kallikrein with detergent treatment. Arch. Biochem. Biophys. 185, 549–556 (1978)
Chao, J, Margolius, H. S.: Purification and properties of rat urinary kallikrein isozymes. Fed. Proc. 36,1014 (1977)
Chao, J, Margolius, H. S.: Identification of kallikrein in toad urinary bladder and skin and its inhibition by amiloride. Clin. Res. 26,63A (1978)
Chao, J, Margolius, H. S.: Identification of kallikrein on external cell surfaces. Fed. Proc. 37, 657 (1978)
Claeson, G.: Chromogenic peptide substrates for kallikreins (to be published)
Colina-Chourio, J, McGiff, J.C, Miller, M.P, Nasjletti, A.: Possible influence of intrarenal generation of kinins on prostaglandin release from the rabbit perfused kidney. Br. J. Pharmacol. 58,165–172 (1976)
Corthorn, J, Imanari, T, Yoshida, H, Kaizu, T, Pierce, J.V, Pisano, J.J.: Inactive kallikrein in human urine. Fed. Proc. 36,893 (1977)
Croxatto, H.R, Albertini, R, Roblero, J, Corthorn, J.: Renal kallikrein (kininogenase activity) in hypertensive rats. Acta Physiol. Lat. Am. 24,439–442 (1974)
Croxatto, H.R, Huidobro, F, Rojas, M, Roblero, J, Albertini, R.: The effect of water, sodium overloading and diuretics upon urinary kallikrein. In: Advances in experimental medicine and biology. Vol. 70: Kinins: Pharmacodynamics and biological roles. Sicuteri, F, Back, N, Haberland, G.L. (eds.), pp. 361–373. New York, London: Plenum Press 1975
Croxatto, H.R, San Martin, M.: Kallikrein-like activity in the urine of renal hypertensive rats. Experientia 26,1216–1217 (1970)
Croxatto, H.R, Roblero, J.S, Garcia, R.L, Corthorn, J.H, San Martin, M.: Urinary kallikrein under furosemide and plasma kininogen levels in normal and hypertensive rats. Acta Physiol. Lat. Am. 23, 556–558 (1973)
DeBono, E, Mills, I. H.: Simultaneous increases in kallikrein in renal lymph and urine during saline infusion. J. Physiol. (Lond.) 241,127P–128P (1974)
Erdös, E. (ed.): Handbook of experimental pharmacology. Vol. XXV: Bradykinin, kallidin, and kallikrein. Berlin, Heidelberg, New York: Springer 1970
Erdös, E.G., Marinkovic, D.M, Ward, P.E, Mills, I.H.: Characterization of urinary kininase. Fed. Proc. 37,657 (1978)
Favaro, S, Baggio, B, Antonello, A, Zen, A, Cannella, G, Todesco, S, Borsatti, A.: Renal kallikrein content of spontaneously hypertensive rats. Clin. Sci. Mol. Med. 49, 69–71 (1975)
Feigen, L.P, Chapnick, B.M, Flemming, J.E, Kadowitz, P.J.: Prostaglandins: renal vascular responses to bradykinin, histamine, and nitroglycerine. Am. J. Physiol. 234, H496–H502 (1978)
Fiedler, F.: Pig pancreatic kallikrein: structure and catalytic properties. In: Chemistry and biology of the kallikrein-kinin system in health and disease. Pisano, J.J, Austen, K.F. (eds.), pp. 93–95. Fogarty Internat. Center Proc. No. 27. Washington: U.S. Gov. Printing Office 1977
Fiedler, F, Hirschauer, C, Werle, E.: Anreicherung von Prakallikrein B aus Schweinepankreas und Eigenschaften verschiedener Formen des Pankreaskallikreins. Hoppe Seylers Z. Physiol. Chem. 351,225–238(1970)
Freeman, R.H, Davies, J.O, Vitale, S.J, Johnson, J.A.: Intrarenal role of angiotensin II. Circ. Res. 32,692–698(1973)
Fritz, H, Fiedler, F, Dietl, T, Warwas, M, Truscheit, E, Kolb, H.J, Mair, G, Tschesche, H.: On the relationships between porcine pancreatic, submandibular, and urinary kallikreins. In: Kininogenases — kallikrein. Haberland, G.L, Rohen, J.W, Suzuki, T. (eds.), Vol. 4, pp. 15–28. New York: Schattauer 1977
Furtado, M.: Inhibition of the permeability response to vasopressin and oxytocin in the toad bladder: Effects of bradykinin, kallidin, eledoisin, and physalaemin. J. Memb. Biol. 4, 165–178 (1971)
Geiger, R, Mann, K.: A kallikrein-specific inhibitor in rat kidney tubules. Hoppe Seylers Z. Physiol. Chem. 357,553–558 (1976)
Geller, R.G, Margolius, H.S, Pisano, J.J, Keiser, H.R.: Effects of mineralocorticoids, altered sodium intake and adrenalectomy on urinary kallikrein in rats. Circ. Res. 31, 857–861 (1972)
Geller, R.G, Margolius, H.S, Pisano, J.J, Keiser, H.R.: Urinary kallikrein in spontaneously hypertensive rats. Circ. Res. 36/37 (Suppl. I), 103–106 (1975)
Geratz, J.D, Cheng, M.C.F, Tidwell, R.R.: New aromatic diamidines with central α-oxyalkane or α, ω-dioxyalkane chains. Structure-activity relationships for the inhibition of trypsin, pancreatic kallikrein, and thrombin and for the inhibition of the overall coagulation process. J. Med. Chem. 18,477–481 (1975)
Geratz, J.D, Cheng, M.C.F, Tidwell, R.R.: Novel bis(benzamidino) compounds with an aromatic central link. Inhibitors of thrombin, pancreatic kallikrein, trypsin, and complement. J. Med. Chem. 19,634–639 (1976)
Gill, J.R, Jr., Melmon, K.L, Gillespie, L, Jr., Bartter, F.C.: Bradykinin and renal function in normal man: effects of adrenergic blockade. Am. J. Physiol. 209,844–848 (1965)
Gill, J.R, Jr., Frolich, J.C, Bowden, R.E, Taylor, A.A, Keiser, H.R, Seyberth, H.W, Oates, J.A, Bartter, F.C.: Bartter’s syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Am. J. Med. 61, 43–51 (1976)
Giusti, E.P, Sampaio, P.A.M., Prado, E.F.: Purification of horse urinary kallikrein by affinity chromatography. In: Kinins 76. An International Symposium (Abs. 43). Rio de Janeiro, Brazil, 1976
Goldberg, L.I, Dollery, C.T, Pentecost, B.L.: Effects of intrarenal infusions of bradykinin and acetylcholine on renal blood flow in man. J. Clin. Invest. 44,1052 (1965)
Grantham, J.J, Orloff, J.: Effect of prostaglandin E1 on the permeability response of the isolated collecting tubule to vasopressin, adenosine 3′,5′-monophosphate, and theophylline. J. Clin. Invest. 47,1154–1161 (1968)
Greco, A.V., Porcelli, G, Croxatto, H.R, Fedeli, G, Ghirlanda, G.: Ipertensione arteriosa e callicreina urinaria. Minerva Med. 65,3058–3062 (1974)
Gulati, O.P, Carretero, O.A, Morino, T, Oza, N.B.: Urinary kallikrein and plasma renin during the reversal of renovascular hypertension in rats. Clin. Sci. Mol. Med. 51 Suppl. 3, 263s–266s (1976)
Guimaraes, J. A, Lu, R. C, Webster, M. E, Pierce, J. V.: Multiple forms of human plasma kininogen. Fed. Proc. 33,641(1974)
Gullner, H.G, Campbell, W.B, Pettinger, W.A.: Substance P: Intrarenal infusion inhibits renin release in the dog. Fed. Proc. 36,984 (1977)
Halushka, P.V, Wohltmann, H, Privitera, P.J, Hurwitz, G, Margolius, H.S.: Bartter’s syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects. Ann. Intern. Med. 87,281–286 (1977)
Halushka, P.V, Margolius, H.S, Allen, H, Conradi, E.C.: Effects of furosemide on the urinary excretion of prostaglandin E-like material and kallikrein. Unpublished results.
Hedqvist, P.: Prostaglandin mediated control of sympathetic neuroeffector transmission. In: Advances in the biosciences. International Conference on Prostaglandins. Bergstro, S, Bernhard, S. (eds.), Vol. 9, pp. 461–473 (1972)
Hial, V., Diniz, C.R, Mares-Guia, M.: Purification and properties of human urinary kallikrein (kininogenase). Biochemistry 13,4311–4318 (1974)
Hilton, S.M, Lewis, G.P.: The mechanism of the functional hyperaemia in the submandibular salivary gland. J. Physiol. (Lond.) 129,253–271 (1955)
Hojima, Y, Isobe, M, Moriya, H.: Kallikrein inhibitors in rat plasma. J. Biochem. 81, 37–46 (1977)
Horwitz, D, Margolius, H. S, Keiser, H. R.: Effects of potassium intake on urinary kallikrein and aldosterone excretion. Clin. Res. 23,221A (1975)
Imanari, T, Kaizu, T, Yoshida, H, Yates, K, Pierce, J.V, Pisano, J.J.: Radiochemical assays for human urinary salivary and plasma kallikreins. In: Chemistry and biology of the kallikreinkinin system in health and disease. Pisano, J.J, Austen, K.F. (eds.), pp. 205–213. Fogarty Internat. Proc. No. 27. Washington: U.S. Gov. Printing Office 1977
Jacobsen, S.: Substrates for plasma kinin-forming enzymes in human, dog, and rabbit plasma. Br. J. Pharmacol. 26,403–411 (1966)
Jenner, S, Croxatto, H.R.: Urinary kallikrein from normal and hypertensive rats. Experientia 29,1359–1361 (1973)
Johnston, C.I, Matthews, P.G, Dax, E.: Effects of dietary sodium, diuretics, and hypertension on renin and kallikrein. In: Systemic effects of antihypertensive agents. Sambhi, M.P. (ed.), pp. 323–338. New York: Stratton Intercontinental 1976
Kaizu, T, Margolius, H. S.: Studies on rat renal cortical cell kallikrein. I. Separation and measurement. Biochim. Biophys. Acta 411,305–315 (1975)
Keiser, H.R, Andrews, M.J, Jr., Guyton, R.A, Margolius, H.S, Pisano, J.J.: Urinary kallikrein in dogs with constriction of one renal artery. Proc. Soc. Exp. Biol. 151, 53–56 (1976)
Lawton, W, Fitz, A.: Normal renin essential hypertension and urinary kallikrein excretion. Clin. Res. 24, 555A (1976)
Lechi, A, Covi, G, Lechi, C, Mantero, F, Scuro, L.A.: Urinary kallikrein excretion in Bartter’s syndrome. J. Clin. Endocrinol. Metab. 43,1175–1178 (1976)
Levy, S.B, Lilley, J.J, Frigon, R.P, Stone, R.A.: Urinary kallikrein and plasma renin activity as determinants of renal blood flow. J. Clin. Invest. 60,129–138 (1977)
Lupu, A.N, Maxwell, M.H, Kaufman, J.J, White, F.N.: Experimental unilateral renal artery constriction in the dog. Circ. Res. 30,561–51A (1972)
MacFarlane, N.A.A, Mills, I.H, Wraight, E.: The effect of kallikrein infusions on renal function in the dog. J. Endocrinol. 55, xli–xlii (1972)
MacFarlane, N.A.A, Adetuyibi, A, Mills, I.H.: The radioimmunoassay of bradykinin in the measurement of kallikrein in urine. J. Endocrinol. 58, xxv (1973)
MacFarlane, N.A.A, Adetuyibi, A, Mills, I.H.: Changes in kallikrein excretion during arterial infusion of angiotensin. J. Endocrinol. 61, lxxii (1974)
Mann, K, Geiger, R, Werle, E.: A sensitive kinin liberating assay for kininogenase in rat urine, isolated glomeruli and tubules of rat kidney. In: Advances in experimental medicine and biology. Vol. 70: Kinins: pharmacodynamics and biological roles. Sicuteri, F, Back, N, Haberland, G.L. (eds.), pp. 65–73. New York, London: Plenum Press 1975
Margolius, H.S, Geller, R, Pisano, J.J, Sjoerdsma, A.: Altered urinary kallikrein excretion in human hypertension. Lancet 1971/11,1063–1065
Margolius, H.S, Geller, R.G, de Jong, W, Pisano, J.J, Sjoerdsma, A.: Urinary kallikrein excretion in hypertension. Circ. Res. 30/31 Suppl. II, 125–131 (1972)
Margolius, H.S, Horwitz, D, Geller, R.G, Alexander, R.W, Gill, J.R, Jr., Pisano, J.J, Keiser, H.R.: Urinary kallikrein excretion in normal man. Relationships to sodium intake and sodium-retaining steroids. Circ. Res. 35, 812–819 (1974a)
Margolius, H.S, Horwitz, D, Pisano, J.J, Keiser, H.R.: Sodium, water, and kallikrein excretion in man. Acta Physiol. Lat. Am. 24,464–468 (1974b)
Margolius, H.S, Horwitz, D, Pisano, J.J, Keiser, H.R.: Urinary kallikrein in hypertension: Relationship to sodium intake and sodium-retaining steroid. Circ. Res. 35, 820–825 (1974c)
Margolius, H.S, Chao, J, Kaizu, T.: The effects of aldosterone and spironolactone on renal kallikrein. Clin. Sci. Mol. Med. 51 Suppl. 3,279s–282s (1976)
Marin-Grez, M.: The influence of antibodies against bradykinin on isotonic saline diuresis in the rat. Pfltigers Arch. 350,231–239 (1974)
Marin-Grez, M, Carretero, O.A.: Urinary kallikrein excretion in rats under low and high sodium intake. Physiologist 14,189 (1971)
Marin-Grez, M, Carretero, O.A.: A method for measurement of urinary kallikrein. J. Appl. Physiol. 32,428–431(1972)
Marin-Grez, M, Cottone, P, Carretero, O.A.: Evidence for an involvement of kinins in regulation of sodium excretion. Am. J. Physiol. 223,794–796 (1972)
Marin-Grez, M, Oza, N.B, Carretero, O.A.: The involvement of urinary kallikrein in the renal escape from the sodium retaining effect of mineralocorticoids. Henry Ford Hospital Med. J. 21,85–90(1973)
McCaa, C.S, McCaa, R. E.: Response of the kallikrein-kinin system to continuous infusion of angiotensin I converting enzyme inhibitor (SQ-20881) into intact conscious dog. Clin. Res. 25,61A (1977)
McGiff, J.C.: Perspective. Bartter’s syndrome results from an imbalance of vasoactive hormones. Ann. Intern. Med. 87,369–372 (1977)
McGiff, J.C, Nasjletti, A.: Kinins, renal function, and blood pressure regulation. Introduction. Fed. Proc. 35,172–174(1976)
McGiff, J.C, Itskovitz, H.D, Terragno, N.A.: The actions of bradykinin and eledoisin in the canine isolated kidney: relationships to prostaglandins. Clin. Sci. Mol. Med. 49, 125–131 (1975)
McGiff, J.C, Itskovitz, H.D, Terragno, A, Wong, P, Y.-K.: Modulation and mediation of the action of the renal kallikrein-kinin system by prostaglandins. Fed. Proc. 35, 175–180 (1976)
McNay, J. L, Goldberg, L. I.: Comparison of the effects of dopamine, isoproterenol, norepinephrine, and bradykinin on canine renal and femoral blood flow. J. Pharmol. Exp. Ther. 151, 23–31 (1966)
Mersey, J. H, Williams, G. H, Hollenberg, N. K, Dluhy, R. G.: Relationship between aldosterone and bradykinin. Circ. Res. 40 Suppl. 1,84–88 (1977)
Mills, I.H, Ward, P. E.: The relationship between kallikrein and water excretion and the conditional relationship between kallikrein and sodium excretion. J. Physiol. (Lond.) 246, 695–707 (1975)
Mills, I.H, Obika, L.F.O.: The effect of adrenergic and dopamine-receptor blockade on the kallikrein and renal response to intra-arterial infusion of dopamine in dogs. J. Physiol. (Lond.) 263,150P–151P (1976)
Mills, I.H, MacFarlane, N.A.A, Ward, P.E.: Increase in kallikrein excretion during the natriuresis produced by arterial infusion of substance P. Nature 247,108–109 (1974)
Mills, I.H, Paterson, C.L, Ward, P.E.: The role of the kidney in the inactivation of injected kallikrein. J. Physiol. (Lond.) 251,281–286 (1975)
Mills, I.H, MacFarlane, N.A.A, Ward, P.E, Obika, L.F.O.: The renal kallikrein-kinin system and the regulation of salt and water excretion. Fed. Proc. 35,181–188 (1976)
Miyashita, A.: Urinary kallikrein determination and its physiological role in human kidney. Jpn. J. Urol. 62,507–518(1971)
Nakano, J.: Effects of synthetic bradykinin on the cardiovascular system. Arch. Intern. Pharmacodyn. 157,1–13 (1965)
Namm, D.H, Squires, J, El-Sayad, S, Wilson, S.J, Parsons, D, Margolius, H.S.: Vascular changes in experimental diabetes mellitus: Development of hypertension and associated changes in arterial metabolism and responsiveness. Unpublished results.
Nasjletti, A, Azzam, M. E.: Variations of plasma kininogen content due to high sodium intake in rats. Experientia 26,280–281 (1970)
Nasjletti, A, Colina-Chourio, J.: Interaction of mineralocorticoids, renal prostaglandins, and the renal kallikrein-kinin system. Fed. Proc. 35,189–193 (1976)
Nasjletti, A, Colina-Chourio, J, McGiff, J. C.: Disappearance of bradykinin in the renal circulation of dogs. Circ. Res. 37,59–65 (1975)
Nekrasova, A.A, Zharova, E.A, Sokolova, R.L: Role of the kallikrein kinin system of the kidneys in sodium and water transport and its modification by indomethacin. Bull. Exp. Biol. Med. 83,456–458 (1977)
Nielsen, K, Arrigoni-Martelli, E.: Effects on rat urinary kallikrein excretion of bumetanide, bendroflumethiazide, and hydralazine. Acta Pharmacol. Toxical. (Kbh.) 40, 267–272 (1977)
Nizet, A.: The isolated perfused kidney: Possibilities, limitations, and results. Kidney Int. 7,1–11 (1975)
Nustad, K.: The relationship between kidney and urinary kininogenase. Br. J. Pharmacol. 39, 73–86 (1970a)
Nustad, K.: Localization of kininogenase in the rat kidney. Br. J. Pharmacol. 39, 87–98 (1970b)
Nustad, K, Pierce, J.V.: Purification of rat urinary kallikreins and their specific antibody. Biochemistry 13,2312–2319 (1974)
Nustad, K, Rubin, I.: Subcellular localization of renin and kininogenase in the rat kidney. Br. J. Pharmacol. 40,326–333 (1970)
Nustad, K, Vaaje, K, Pierce, J.V.: Synthesis of kallikreins by rat kidney slices. Br. J. Pharmacol. 53,229–234(1975)
Ofstad, E.: Formation and destruction of plasma kinins during experimental acute hemorrhagic pancreatitis in dogs. Scand. J. Gastroenterol. 5 Suppl. 5,1–44 (1970)
Ole-Moi Yoi, O, Spragg, J, Halbert, S.P., Austen, K.F.: Immunologic reactivity of purified human urinary kallikrein (urokallikrein) with antiserum directed against human pancreas. J. Immunol. 118,667–672 (1977)
Olsen, U. B, Ahnfelt-Rønne, J.: Bumetanide-induced increase of renal blood flow in conscious dogs and its relation to local renal hormones (PGE, kallikrein and renin). Acta Pharmacol. Toxicol. (Kbh.) 38,219–228 (1976)
Orstavik, T. B, Gautvik, K. M.: Regulation of salivary kallikrein secretion in the rat sulmand bular gland. Acta Physiol. Scand. 100,33–44 (1977)
Orstavik, T.B, Nustad, K, Brandtzaeg, P, Pierce, J.V.: Cellular origin of urinary kallikreins. J. Histochem. Cytochem. 24,1037–1039 (1976)
Oza, N. B, Amin, V. M, Gandolfi, R, Yanari, S, Carretero, O. A.: A direct radioimmunoassay for rat urinary kallikrein. Fed. Proc. 35,693 (1976a)
Oza, N.B, Amin, V.M, McGregor, R.K, Scicli, A.G, Carretero, O.A.: Isolation of rat urinary kallikrein and properties of its antibodies. Biochem. Pharmacol. 25, 1607–1612 (1976b)
Pierce, J.V, Nustad, K.: Purification of human and rat urinary kallikrein. Fed. Proc. 31, 623 (1972)
Pisano, J.J, Yates, K, Pierce, J.V.: Kininogen in human urine. Agents Actions 8, 153 (1978)
Porcelli, G, Croxatto, H.: Purification of kininogenase from rat urine. Ital. J. Biochem. 20, 66–88 (1971)
Porcelli, G, Marini-Bertolo, G.B, Croxatto, H.R, di Iorio, M.: Purification and chemical studies on human urinary kallikrein. Ital. J. Biochem. 23,44–55 (1974)
Porcelli, G, Bianchi, G, Croxatto, H.: Urinary kallikrein in a spontaneously hypertensive strain of rats. Proc. Soc. Exp. Biol. 149,983–986 (1975)
Rapp, J.R, Pan, S.Y., Margolius, H.S.: Plasma renin, adrenocorticoids in urinary kallikrein in salt-sensitive and salt-resistant rats. Endo. Res. Comm. 5,35–41 (1978)
Roblero, J.S, Croxatto, H. R, Albertini, R.B.: Release of renal kallikrein to the perfusate by isolated rat kidney. Experientia 32,1440–1441 (1976a)
Roblero, J, Croxatto, H, Garcia, R, Corthorn, J, DeVito, E.: Kallikreinlike activity in perfusates and urine of isolated rat kidneys. Am. J. Physiol. 231,1383–1389 (1976b)
Scicli, A.G, Carretero, O.A, Oza, N.B, Schork, A.: Distribution of kidney kininogenases. Proc. Soc. Exp. Biol. Med. 151, 57–60 (1976)
Scicli, A.G, Gandolfi, R, Carretero, O. A.: Site of kinin formation in the dog nephron. Fed. Proc. 36,1015(1977)
Scicli, A.G., Gandolfi, R, Carretero, O. A.: Site of formation of kinins in the dog nephorn. Am. J. Physiol. 234, F36–F40 (1978)
Silva, E, Diniz, C.R, Mares-Guia, M.: Rat urinary kallikrein: Purification and properties. Biochemistry 13,4304–4310 (1974)
Seino, J, Abe, K, Otsuka, Y, Saito, T, Irokawa, N, Yasujima, M, Ciba, S, Yoshinaga, K.: Urinary kallikrein excretion and sodium metabolism in hypertensive patients. Tohoku J. Exp. Med. 116, 359–367 (1975)
Seino, M, Abe, K, Sakurai, Y, Irokawa, N, Yasujima, M, Chiba, S, Otsuka, Y, Yoshinaga, K.: Effect of spironolactone on urinary kallikrein excretion in patients with essential hypertension and in primary aldosteronism. Tohoku J. Exp. Med. 121,111–119 (1977)
Seino, M, Abe, K, Irokawa, N, Ito, T, Yasujima, M, Sakurai, Y, Chiba, S, Saito, K, Ritz, K, Kusaka, T, Miyazaki, S, Yoshinaga, K.: Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension. Tohoku J. Exp. Med. 124,197–203 (1978)
Stein, J.H., Ferris, T.F., Huprich, J.E, Smith, T.C., Osgood, R.W.: Effect of renal vasodilation on the distribution of cortical blood flow in the kidney of the dog. J. Clin. Invest. 50, 1429–1438 (1971)
Stein, J.H, Congbalay, R.C, Karsh, D.L., Osgood, R.W, Ferris, T.F.: The effect of bradykinin on proximal tubular sodium reabsorption in the dog: Evidence for functional nephron heterogeneity. J. Clin. Invest. 51,1709–1721 (1972)
Streeten, D.H.P, Kerr, L.P, Kerr, C.B, Prior, J.C, Dalakos, T.G.: Hyperbradykininism: A new orthostatic syndrome. Lancet 1972/11,1048–1053
Takahachi, H, Iwanaga, S, Suzuki, T.: Snake venom proteinase inhibitors. I. Isolation and properties of two inhibitors of kallikrein, trypsin, and alpha-kimotrypsin from the venom of Russell’s viper (Vipera russelli). J. Biochem. (Tokyo) 76,709–713 (1974)
Talamo, R.C, Haber, E, Austen, K.F.: A radioimmunoassay for bradykinin in plasma and synovial fluid. J. Lab. Clin. Med. 74,816–827 (1969)
Tidwell, R.R., Fox, L.L, Geratz, J.D.: Aromatic Tris-amidines. A new class of highly active inhibitors of trypsin-like proteases. Biochim. Biophys. Acta 445,729–738 (1976)
Trautschold, I.: Assay methods in the kinin system. In: Handbook of experimental pharmacology. Vol. XXV: Bradykinin, kallidin, and kallikrein. Erdös, E.G. (ed.), pp. 52–81. Berlin, Heidelberg, New York: Springer 1970
Tyler, D.W.: The distribution and properties of renal kininogenase. Ph.D. Thesis. University of Alberta, Edmondon, Alberta, 1972
Vinci, J.M, Telles, D.A, Bowden, R.E, Izzo, J.L, Keiser, H.R, Radfar, N, Taylor, A.A, Gill, J.R, Jr., Bartter, F.C.: The kallikrein-kinin system in Bartter’s syndrome and its response to prostaglandin synthetase inhibition. Clin. Res. 24,414A (Abstract) (1976)
Vinci, J, Zusman, R, Bowden, R, Horwitz, D, Keiser, H.: Relationship of urinary and plasma kinins to sodium-retaining steroids and plasma renin activity. Clin. Res. 25, 450A (Abstract) (1977)
Ward, P.E, Johnson, A. R.: Renal inactivation of substance P in the rat. Biochem. J. 171, 143–148 (1978)
Ward, P.E, Gedney, C, Dowden, R.M, Erdös, E.G.: Subcellular localization of renal kallikrein. Circulation 52,11–14 (1975a)
Ward, P.E, Gedney, C, Dowden, R.M, Erdös, E.G.: Isolation of membrane-bound renal kallikrein and kininase. Biochem. J. 151,755–758 (1975b)
Ward, P.E, Erdös, E. G, Gedney, C. D, Dowden, R. M, Reynolds, R. C.: Isolation of membrane bound renal enzymes that metabolize kinins and antiotensins. Biochem. J. 157, 643–650 (1976)
Ward, P. E, Schultz, W, Reynolds, R. C, Erdös, E. G.: Metabolism of kinins and angiotensin in the isolated glomerulus and brush border of rat kidney. Lab. Invest. 36, 599–606 (1977)
Webster, M.E, Gilmore, J.P.: Influence of kallidin-10 on renal function. Am. J. Physiol. 206, 714–718 (1964)
Webster, M.E, Pierce, J.V.: Action of the Kallikreins on synthetic ester substrates. Proc. Soc. Exp. Biol. 107,186–191 (1961)
Webster, M.E, Pierce, J.V.: The nature of the kallidins released from human plasma by kallikreins and other enzymes. Ann. N.Y. Acad. Sci. 104,91–107 (1963)
Werle, E., Vogel, R.: Über die Kallikreinausscheidung im Harn nach experimenteller Nierenschadigung. Archs. Int. Pharmacodyn. Ther. 126,171–186 (1960)
Willis, L.R, Ludens, J.H., Hook, J.B, Williamson, H.E.: Mechanism of natriuretic action of bradykinin. Am. J. Physiol. 217,1–5 (1969)
Wilson, C.M., Ward, P.E., Erdös, E.G., Geese, A.: Studies on membrane bound renin in the mouse and rat. Circ. Res. 38, ii95–ii98 (1976)
Wong, P.Y, Talamo, R.C, Williams, G.H, Coleman, R.W.: Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture. J. Clin. Invest. 55, 691–698 (1975)
Zinner, S.H, Margolius, H.S, Rosner, B, Keiser, H.R, Kass, E.H.: Familial aggregation of urinary kallikrein concentration in childhood. Am. J. Epidemiol. 104,124–132 (1976)
Zinner, S.H, Margolius, H.S, Rosner, B, Kass, E.H.: Eight year longitudinal study of blood pressure and urinary kallikrein in childhood. Clin. Res. 25,266A (1977)
Zusman, R.M, Keiser, H.R.: Prostaglandin biosynthesis by rabbit renomedullary interstitial cells in tissue culture: stimulation by vasoactive peptides. J. Clin. Invest. 60, 215–223 (1977a)
Zusman, R.M, Keiser, H.R.: Prostaglandin E2 biosynthesis by rabbit renomedullary interstitial cells in tissue culture. Mechanism of stimulation by angiotensin II, bradykinin, and arginine vasopressin. J. Biol. Chem. 252,2069–2071 (1977b)
Zusman, R.M, Keiser, H.R, Handler, J.F.: Vasopressin-stimulated water permeability in the toad urinary bladder: role of endogenous prostaglandin E biosynthesis. Fed. Proc. 36, 631 (Abstract) (1977)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ward, P.E., Margolius, H.S. (1979). Renal and Urinary Kallikreins. In: Erdös, E.G. (eds) Bradykinin, Kallidin and Kallikrein. Handbook of Experimental Pharmacology, vol 25 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67301-6_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-67301-6_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-67303-0
Online ISBN: 978-3-642-67301-6
eBook Packages: Springer Book Archive